Protective effect and potential mechanism of Ginkgo biloba extract EGb 761 on STZ-induced neuropathic pain in rats

Phytotherapy Research

Volumn 26, Issue 12, 2012, Pages 1823-1829

  Taliyan, Rajeev ^a,b   Sharma, P L ^a  

^a ISF COLLEGE OF PHARMACY   (India)

^b BIRLA INSTITUTE OF TECHNOLOGY AND SCIENCE   (India)

Author keywords

allodynia; hyperanalgaesic; neuropathy; streptozotocin

Indexed keywords

CATALASE; GINKGO BILOBA EXTRACT; NITRIC OXIDE; PREGABALIN; STREPTOZOCIN; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCE;

ALLODYNIA; ANALGESIC ACTIVITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIABETIC NEUROPATHY; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG INHIBITION; DYNAMIC PLANTAR AESTHESIOMETER; ENZYME BLOOD LEVEL; FEMALE; HYPERALGESIA; MALE; MEDICAL DEVICE; NEUROPATHIC PAIN; NEUROPROTECTION; NITROSATIVE STRESS; NONHUMAN; OXIDATIVE STRESS; PAIN ASSESSMENT; PAIN THRESHOLD; PROTEIN BLOOD LEVEL; RAT; STREPTOZOCIN DIABETES; TREATMENT DURATION; TREATMENT RESPONSE;

ANALGESICS; ANIMALS; CATALASE; DIABETIC NEUROPATHIES; FEMALE; HOT TEMPERATURE; HYPERALGESIA; LIPID PEROXIDATION; MALE; NEURALGIA; NITRIC OXIDE; OXIDATIVE STRESS; PAIN THRESHOLD; PLANT EXTRACTS; RATS; STREPTOZOCIN; SUPEROXIDE DISMUTASE; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

GINKGO BILOBA; RATTUS;

EID: 84871333478     PISSN: 0951418X     EISSN: 10991573     Source Type: Journal    
DOI: 10.1002/ptr.4648     Document Type: Article

References (33)

1. Abdel-Salam OM, Baiuomy AR, El-batran S, Arbid MS,. 2004. Evaluation of the anti-inflammatory, anti-nociceptive and gastric effects of Ginkgo biloba in the rat. Pharmacol Res 49: 133-142.
2. Ahlemeyer B, Krieglstein J,. 2003. Neuroprotective effects of Ginkgo biloba extract. Cell Mol Life Sci 60: 1779-192.
3. Anjaneyulu M, Chopra K,. 2004. Quercetin attenuates thermal hyperalgesia cold allodynia in STZ-induced diabetic rats. Indian J Exp Biol 42: 766-769.
4. Cameron NE, Cotter MA,. 2008. Pro-inflammatory mechanisms in diabetic neuropathy: focus on the nuclear factor kappa B pathway. Curr Drug Targets 9 (1): 60-67.
5. Comelli F, Bettoni I, Colleoni M, Giagnoni G, Costa B,. 2009. Beneficial effects of a Cannabis sativa extract treatment on diabetes-induced neuropathy and oxidative stress. Phytother Res 23 (12): 1678-1684.
6. Courteix C, Eschalier A, Lavarenne J,. 1993. Streptozocin-induced diabetic rats: behavioural evidence for a model of chronic pain. Pain 53: 81-88.
7. Du ZY, Li XY,. 1998. Effects of ginkgolides on interleukin-1, tumor necrosis factor-alpha and nitric oxide production by rat microglia stimulated with lipopolysaccharides in vitro. Arzneimittelforschung 48: 1126-1130.
8. Friederich M, Hansell P, Palm F,. 2009. Diabetes, oxidative stress, nitric oxide and mitochondria function. Curr Diabetes Rev 5 (2): 120-144.
9. Green LC, Wagner DA, Glogowski J, et al,. 1982. Analysis of nitrate, nitrite, and [15N] nitrate in biological fluids. Anal Biochem 126 (1): 131-138.
10. Hargreaves KM, Dubner R, Brown F, Flores C, Joris J,. 1988. A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia. Pain 32: 77-88.
11. Hibatallah J, Carduner C, Poelman MC,. 1999. In-vivo and in-vitro assessment of the free-radical-scavenger activity of Ginkgo flavone glycosides at high concentration. J Pharm Pharmacol 51: 1435-1440.
12. Iwase M, Nunoi K, Sadoshima S, Kikuchi M, Fujishima M,. 1989. Liver, kidney and islet cell tumours in spontaneously hypertensive and normotensive rats treated neonatally with streptozotocin. Tohoku J Exp Med 159 (2): 83-90.
13. Joharchi K, Jorjani M,. 2007. The role of nitric oxide in diabetes-induced changes of morphine tolerance in rats. Eur J Pharmacol 570 (1-3): 66-71.
14. Kakkar P, Das B, Viswanathan PN,. 1984. A modified spectrophotometric assay of superoxide dismutase. Indian J Biochem Biophys 21: 130-132.
15. Kim YS, Park HJ, Kim TK, Moon DE, Lee HJ,. 2009. The effects of Ginkgo biloba extract EGb 761 on mechanical and cold allodynia in a rat model of neuropathic pain. Anesth Analg 108 (6): 1958-1963.
16. Kolb H, Kroncke KD,. 1993. IDDM: lessons from the low-dose streptozotocin model in mice. Diabetes Rev 1: 116-126.
17. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ,. 1951. Protein measurement with the Folin-Phenol reagents. J Biol Chem 193: 265-275.
18. Obrosova IG, Mabley JG, Zsengeller Z, et al,. 2005. Role for nitrosative stress in diabetic neuropathy: evidence from studies with a peroxynitrite decomposition catalyst. FASEB J 19: 401-403.
19. Obrosova IG, Drel VR, Oltman CL, et al,. 2007. Role of nitrosative stress in early neuropathy and vascular dysfunction in streptozotocin-diabetic rats. Am J Physiol Endocrinol Metab 293 (6): E1645-1655.
20. Ohkawa H, Ohishi N, Yagi K,. 1979. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 95: 351-358.
21. Ozkul A, Ayhan M, Yenisey C, Akyol A, Guney E, Ergin FA,. 2010. The role of oxidative stress and endothelial injury in diabetic neuropathy and neuropathic pain. Neuro Endocrinol Lett 31 (2): 261-264.
22. Pabbidi RM, Cao DS, Parihar A, Pauza ME, Premkumar LS,. 2008. Direct role of streptozotocin in inducing thermal hyperalgesia by enhanced expression of transient receptor potential vanilloid 1 in sensory neurons. Mol Pharmacol 73 (3): 995-1004.
23. Raz I, Hasdai D, Seltzer Z, Melmed RN,. 1988. Effect of hyperglycemia on pain perception and on efficacy of morphine analgesia in rats. Diabetes 37: 1253-1259.
24. Shi C, Liu J, Wu F, Yew DT,. 2010. Ginkgo biloba extract in Alzheimer's disease: From action mechanisms to medical practice. Int J Mol Sci 11 (1): 107-123.
25. Sinha AK,. 1972. Colorimetric assay of catalase. Anal Biochem 47: 389-394.
26. Song W, Guan HJ, Zhu XZ, Chen ZL, Yin ML, Cheng XF,. 2000. Protective effect of bilobalide against nitric oxide-induced neurotoxicity in PC12 cells. Acta Pharmacol Sin 21: 415-420.
27. Taliyan R, Sharma PL,. 2012. Possible mechanism of protective effect of thalidomide in STZ-induced-neuropathic pain behavior in rats. Inflammopharmacol. DOI: 10.1007/s10787-011-0106-4
28. Taliyan R, Singh M, Sharma PL,. 2010. Beneficial effect of cyclosporine in experimental diabetes induced neuropathic pain in rats. Int J Pharmacol 6: 355-361.
29. Yu LN, Yang XS, Hua Z, Xie W,. 2009. Serum levels of pro-inflammatory cytokines in diabetic patients with peripheral neuropathic pain and the correlation among them. Zhonghua Yi Xue Za Zhi 89 (7): 469-471.
30. Zhao HW, Li XY,. 2002. Ginkgolide A, B, and huperzine A inhibit nitric oxide-induced neurotoxicity. Int Immunopharmacol 2: 1551-1556.
31. Ziegler D,. 2008. Treatment of diabetic neuropathy and neuropathic pain. How far have we come? Diabetes Care 31 (2): S255-S261.
32. Ziegler D,. 2010. Can diabetic polyneuropathy be successfully treated? MMW Fortschr Med 152 (9): 64-68.
33. Zimmermann M,. 1983. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 16: 109-110.